These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 2715912)
1. Microencapsulated monosialoganglioside GM1: physical properties and in vivo effects. Maysinger D; Jalsenjak V; Stolnik S; Garofalo L; Cuello AC; Jalsenjak I J Microencapsul; 1989; 6(1):35-42. PubMed ID: 2715912 [TBL] [Abstract][Full Text] [Related]
2. Effects of microencapsulated monosialoganglioside GM1 on cholinergic neurons. Maysinger D; Garofalo L; Jalsenjak I; Cuello AC Brain Res; 1989 Sep; 496(1-2):165-72. PubMed ID: 2804628 [TBL] [Abstract][Full Text] [Related]
3. Nerve growth factor and the monosialoganglioside GM1: analogous and different in vivo effects on biochemical, morphological, and behavioral parameters of adult cortically lesioned rats. Garofalo L; Cuello AC Exp Neurol; 1994 Feb; 125(2):195-217. PubMed ID: 8313938 [TBL] [Abstract][Full Text] [Related]
4. Lesions of the nucleus basalis magnocellularis in the rat: morphological, biochemical and behavioral reparative effect of nerve growth factor and ganglioside GM1. Casamenti F; Milan F; Pepeu G Acta Neurobiol Exp (Wars); 1990; 50(4-5):461-73. PubMed ID: 2130662 [TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of nerve growth factor and/or monosialoganglioside GM1 effects on cholinergic markers in the adult lesioned brain. Garofalo L; Cuello AC J Pharmacol Exp Ther; 1995 Feb; 272(2):527-45. PubMed ID: 7853166 [TBL] [Abstract][Full Text] [Related]
6. Potentiation of nerve growth factor-induced alterations in cholinergic fibre length and presynaptic terminal size in cortex of lesioned rats by the monosialoganglioside GM1. Garofalo L; Ribeiro-da-Silva A; Cuello AC Neuroscience; 1993 Nov; 57(1):21-40. PubMed ID: 8278055 [TBL] [Abstract][Full Text] [Related]
7. GM1 ganglioside protects nucleus basalis from excitotoxin damage: reduced cortical cholinergic losses and animal mortality. Mahadik SP; Vilim F; Korenovsky A; Karpiak SE J Neurosci Res; 1988 Aug; 20(4):479-83. PubMed ID: 3184210 [TBL] [Abstract][Full Text] [Related]
8. Effects of treatment with microencapsulated monosialoganglioside GM1 on cortical and striatal acetylcholine release in rats with cortical devascularizing lesions. Maysinger D; Herrera-Marschitz M; Ungerstedt U; Cuello AC Neurosci Lett; 1990 Oct; 118(2):252-6. PubMed ID: 2274279 [TBL] [Abstract][Full Text] [Related]
9. Evidence for nerve growth factor-ganglioside interaction in forebrain cholinergic neurons. Cuello AC; Garofalo L; Maysinger D Acta Neurobiol Exp (Wars); 1990; 50(4-5):451-60. PubMed ID: 2130661 [TBL] [Abstract][Full Text] [Related]
10. Monosialoganglioside cotreatment prevents haloperidol treatment-associated loss of cholinergic enzymes in rat brain. Mahadik SP; Mukherjee S Biol Psychiatry; 1995 Aug; 38(4):246-54. PubMed ID: 8547447 [TBL] [Abstract][Full Text] [Related]
11. Neural plasticity of basal forebrain cholinergic neurons: effects of gangliosides. Stephens PH; Tagari PC; Garofalo L; Maysinger D; Piotte M; Cuello AC Neurosci Lett; 1987 Sep; 80(1):80-4. PubMed ID: 3658235 [TBL] [Abstract][Full Text] [Related]
12. Analysis of the time course of GM1 ganglioside effect on changes in choline acetyltransferase activity in partially denervated rat hippocampus. Skup M; Gradkowska M; Ułas J; Oderfeld-Nowak B Acta Neurobiol Exp (Wars); 1987; 47(5-6):199-211. PubMed ID: 3445796 [TBL] [Abstract][Full Text] [Related]
13. Effects of coencapsulated NGF and GM1 in rats with cortical lesions. Maysinger D; Filipovic-Grcic J; Cuello AC Neuroreport; 1993 Jul; 4(7):971-4. PubMed ID: 8369492 [TBL] [Abstract][Full Text] [Related]
14. Gangliosides potentiate in vivo and in vitro effects of nerve growth factor on central cholinergic neurons. Cuello AC; Garofalo L; Kenigsberg RL; Maysinger D Proc Natl Acad Sci U S A; 1989 Mar; 86(6):2056-60. PubMed ID: 2928318 [TBL] [Abstract][Full Text] [Related]
15. Interaction between nerve growth factor and GM1 monosialoganglioside in preventing cortical choline acetyltransferase and high affinity choline uptake decrease after lesion of the nucleus basalis. Di Patre PL; Casamenti F; Cenni A; Pepeu G Brain Res; 1989 Feb; 480(1-2):219-24. PubMed ID: 2713652 [TBL] [Abstract][Full Text] [Related]
16. Long-term protective effects of human recombinant nerve growth factor and monosialoganglioside GM1 treatment on primate nucleus basalis cholinergic neurons after neocortical infarction. Liberini P; Pioro EP; Maysinger D; Ervin FR; Cuello AC Neuroscience; 1993 Apr; 53(3):625-37. PubMed ID: 8487947 [TBL] [Abstract][Full Text] [Related]
17. Impairment of basal forebrain cholinergic neurons associated with aging and long-term loss of ovarian function. Gibbs RB Exp Neurol; 1998 Jun; 151(2):289-302. PubMed ID: 9628764 [TBL] [Abstract][Full Text] [Related]
18. Trophic factor effects on cholinergic innervation in the cerebral cortex of the adult rat brain. Cuello AC; Maysinger D; Garofalo L Mol Neurobiol; 1992; 6(4):451-61. PubMed ID: 1285934 [TBL] [Abstract][Full Text] [Related]
19. Comparison of nerve growth factor's effects on development of septum, striatum, and nucleus basalis cholinergic neurons in vitro. Hartikka J; Hefti F J Neurosci Res; 1988; 21(2-4):352-64. PubMed ID: 3216428 [TBL] [Abstract][Full Text] [Related]
20. Limited neocortical devascularizing lesions causing deficits in memory retention and choline acetyltransferase activity--effects of the monosialoganglioside GM1. Elliott PJ; Garofalo L; Cuello AC Neuroscience; 1989; 31(1):63-76. PubMed ID: 2771061 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]